Does Security Health Plan Cover Mounjaro?
The verdict
Conditional on most plans
Security Health Plan (Marshfield Clinic, Wisconsin) covers Mounjaro for type 2 diabetes with prior authorization — the diabetes-only pattern is inferred from the near-universal insurer baseline, not from a directly retrieved Security Health Plan formulary line; verify on plan formulary. Mounjaro is not covered for weight loss under any line of business. The weight-loss tirzepatide is Zepbound, which has separate and often-excluded coverage.
Coverage is set by your specific plan and formulary. This is a research summary — always confirm with Security Health Plan using your member ID.
Key facts
Security Health Plan (Marshfield Clinic, Wisconsin) is a regional composite carrier. Its Mounjaro coverage for T2D follows the near-universal diabetes-only pattern, but drug-level tier specifics are not publicly confirmed — always verify on the plan formulary.
Security Health Plan, member services; composite insurer pattern per CMS/PBM baseline data
The 2026 Medicare Part D out-of-pocket cap is $2,100. Most enrollees on Mounjaro for T2D reach this cap within 2–3 months and pay $0 for the remainder of the year.
CMS.gov, Medicare Part D Redesign 2025–2026
The IRA-negotiated Medicare MFN price for tirzepatide (Mounjaro) is $245/month, effective mid-2026 for Medicare enrollees.
CMS.gov, IRA Drug Price Negotiation Program, 2026
Medicare vs. commercial coverage
Whether Security Health Plan covers Mounjaro depends heavily on which kind of plan you hold. They follow completely different rules — here's each one, side by side.
Medicare
Part D & Advantage plans
Security Health Plan Medicare Part D plans cover Mounjaro for type 2 diabetes only — not weight loss — with prior authorization, per the standard Part D diabetes pattern. The 2026 Part D out-of-pocket cap is $2,100; most continuous Mounjaro users for diabetes reach it within 2–3 months and pay $0 thereafter. The IRA-negotiated Medicare MFN price of $245/month begins mid-2026. Mounjaro is NOT included in the 2026 Medicare GLP-1 Bridge ($50/month, July 1 – December 31, 2027), which covers weight-loss-approved products only (Wegovy, Foundayo, Zepbound KwikPen). The Lilly savings card is not usable by Medicare beneficiaries. Verify coverage details on the Security Health Plan Medicare Part D formulary.
Commercial / Employer
Group & marketplace plans
Commercial/Employer: Security Health Plan commercial plans cover Mounjaro for T2D with prior authorization (composite pattern — verify on Security Health Plan formulary). Not covered for off-label weight loss. ACA/Individual: diabetes only, PA; weight-loss GLP-1s are commonly excluded on ACA plans. Verify on plan formulary for your specific Security Health Plan ACA product. Medicaid (WI): Wisconsin Medicaid is diabetes-focused; Mounjaro is covered for T2D with PA per the WI PDL. Weight-loss GLP-1 use is excluded. The Lilly savings card is not available to Medicaid beneficiaries. Because Security Health Plan is a regional Wisconsin carrier, drug-level formulary details are not publicly confirmed at the national level — always verify on the plan formulary or member services.
The 5 boxes you must tick to get approved
Commercial plans that will consider Mounjaro require prior authorization. Check off what applies to you to see how close you are — this is a guide, not a guarantee of approval.
Meet all 5 and you have a documented case for approval. Missing any one is the most common reason requests are denied.
Your cost, three ways
What Mounjaro actually costs you swings enormously depending on how it's covered. Here's the realistic range.
Paying cash
Approximately $1,300–$1,560/month retail (WAC ~$1,080). Lilly savings card: $499/month for commercially insured patients without coverage (max $647/month, up to 13 fills, expires 12/31/2026). Not available to Medicare or Medicaid beneficiaries.
List price with no coverage — before any manufacturer savings card.
With coverage
Commercial: plan-specific cost-share not publicly confirmed — verify on Security Health Plan formulary. Lilly savings card: as low as $25/month for commercially insured patients with coverage. Medicare Part D: 25% coinsurance after deductible to the $2,100 OOP cap 2026; MFN $245/month mid-2026. WI Medicaid: nominal cost-share per WI PDL.
Typical monthly copay once prior authorization is approved.
Bridge program
The 2026 Medicare GLP-1 Bridge ($50/month) covers weight-loss-approved products only (Wegovy, Foundayo, Zepbound KwikPen). Mounjaro is not included.
Reduced copay through the assistance program, where eligible.
All figures are estimates; actual cost-share varies by Security Health Plan product and pharmacy. Because Security Health Plan is a regional composite, drug-level tier specifics are not publicly confirmed — confirm tier and copay on the plan formulary or by calling member services. The Lilly savings card applies only to commercially insured patients and expires 12/31/2026.
Check YOUR exact coverage in 3 steps
General answers only get you so far. Here's how to confirm your own plan's decision in a few minutes.
- 1
Look up Mounjaro on the Security Health Plan formulary
Visit securityhealth.org or call Security Health Plan member services and ask for the plan formulary (drug list) for your specific product. Enter 'Mounjaro' or 'tirzepatide'. Confirm it is listed for type 2 diabetes (E11.x), note the tier, and check whether prior authorization is required. Because Security Health Plan is a regional carrier, formulary details may not be replicated on national drug-lookup tools — go directly to the plan.
- 2
Have your prescriber submit the prior authorization
Your prescriber needs to document your confirmed T2D diagnosis, A1c of 6.5% or higher, and prior oral agent step therapy (metformin plus typically one additional agent). Ask your prescriber's office to submit a PA request to Security Health Plan. Verify the exact PA criteria on the Security Health Plan formulary before submission, as criteria for regional plans may differ from national PBM composites.
- 3
Call Security Health Plan member services to confirm cost
Call the number on the back of your Security Health Plan card. Ask: Is Mounjaro covered for type 2 diabetes on my specific plan? What is my cost-share after prior authorization? Is the 2026 Medicare GLP-1 Bridge applicable to Mounjaro on my plan? (Answer: No — Mounjaro is excluded from the Bridge because it is a diabetes drug, not a weight-loss product.)
Options if Security Health Plan won't cover Mounjaro
A denial isn't the end of the road. These are the paths people commonly explore next — discuss any of them with your prescriber.
Ozempic (semaglutide)
FDA-approved for type 2 diabetes. Often covered with PA on commercial and Medicare Part D plans; may be at a more favorable tier than Mounjaro — verify on Security Health Plan formulary.
Trulicity (dulaglutide)
FDA-approved for T2D. GLP-1 alternative with lower list price than Mounjaro; often preferred tier on regional and Medicaid formularies — verify on plan.
Jardiance (empagliflozin)
SGLT2 inhibitor for T2D with cardiovascular benefits. Often preferred tier; may be required as step therapy before GLP-1 approval. Verify on Security Health Plan formulary.
Zepbound (tirzepatide) — weight loss only
Same molecule as Mounjaro (tirzepatide) but FDA-approved for chronic weight management and obstructive sleep apnea — not diabetes. Has separate and often-excluded coverage; included in the 2026 Medicare GLP-1 Bridge for weight-loss-approved products. Do not substitute Mounjaro for Zepbound — they are different FDA approvals.
These options are listed for information only — your own clinician decides what is appropriate for you.
❓Frequently Asked Questions
No. Mounjaro is FDA-approved for type 2 diabetes only — not weight loss. No insurer, including Security Health Plan, covers Mounjaro for off-label weight loss; those requests are denied. The weight-loss version of tirzepatide is Zepbound, which has separate and often-excluded coverage. If weight loss is your goal, verify Zepbound coverage separately on the Security Health Plan formulary.
Mounjaro and Zepbound contain the same active ingredient (tirzepatide) but have different FDA approvals. Mounjaro is approved for type 2 diabetes; Zepbound is approved for chronic weight management and obstructive sleep apnea. Security Health Plan follows the standard insurer pattern: Mounjaro is coverable for diabetes with prior authorization; Zepbound has separate coverage that must be verified independently on the plan formulary.
Security Health Plan is a regional Wisconsin carrier, and its drug-level formulary details are not publicly confirmed at the national level. The diabetes-only coverage pattern is inferred from the near-universal insurer baseline. Verify directly on securityhealth.org or by calling Security Health Plan member services — do not rely on national drug-lookup tools for tier or cost-share specifics.
Commercial cost-share is not publicly confirmed for Security Health Plan — verify on the plan formulary. The Lilly savings card can reduce cost to as little as $25/month for commercially insured patients with coverage, or $499/month without (expires 12/31/2026; excludes Medicare and Medicaid). Medicare Part D: 25% coinsurance to the $2,100 OOP cap 2026; MFN $245/month mid-2026.
Wisconsin Medicaid is diabetes-focused, and Mounjaro is covered for T2D with prior authorization per the WI PDL. Weight-loss GLP-1 use is excluded. Mounjaro is not in the 2026 Medicare GLP-1 Bridge, which covers weight-loss-approved products only. Verify current WI Medicaid PDL status on Wisconsin's state Medicaid preferred drug list or Security Health Plan member services.
Related Articles
Does Geisinger Health Plan Cover Mounjaro? 2026 Guide | Curex
Geisinger covers Mounjaro for type 2 diabetes with prior auth — not weight loss. PA Medicaid is diabetes-only after the 2025 weight-loss GLP-1 cut.
Read moreDoes Tufts Health Plan Cover Mounjaro? 2026 Guide | Curex
Tufts Health Plan covers Mounjaro for type 2 diabetes with prior auth — not weight loss. MA Medicaid covers diabetes; weight-loss GLP-1s restricted.
Read moreDoes Harvard Pilgrim Health Care Cover Mounjaro? 2026 | Curex
Harvard Pilgrim (Point32Health) covers Mounjaro for type 2 diabetes with PA — not weight loss. MA Medicaid covers diabetes; weight-loss GLP-1s restricted.
Read moreDoes UPMC Health Plan Cover Mounjaro? 2026 | Curex
UPMC Health Plan covers Mounjaro for type 2 diabetes with prior auth in western PA — not weight loss. PA Medicaid cut weight-loss GLP-1s in 2025.
Read moreDoes Health Net Cover Mounjaro? California 2026 | Curex
Health Net (Centene, CA) covers Mounjaro for type 2 diabetes with prior auth — not weight loss. Medi-Cal excludes weight-loss GLP-1s from 1/1/2026.
Read moreDoes Group Health Cooperative Cover Mounjaro? 2026 | Curex
Group Health Cooperative (GHC, WI) covers Mounjaro for type 2 diabetes with prior auth — not weight loss. Composite; verify on plan formulary.
Read moreInsurance covers Mounjaro only for diabetes — for weight loss, here's a path that skips insurance
Security Health Plan covers Mounjaro for diabetes only, not weight loss — the weight-loss twin Zepbound is a separate, often-excluded question. For patients who want tirzepatide access without insurance, compounded tirzepatide from $149/mo (and compounded semaglutide from $49/mo) is available at getcurex.com/cl/glp — no insurance required, no prior authorization. This is compounded tirzepatide and is not the same medication as Mounjaro or Zepbound. Prescription required, subject to provider review.
- Medication + free shipping
- 24/7 provider access
- Medical intake & prescription review
Compounded semaglutide and tirzepatide are not the same medications as Mounjaro and are not branded or FDA-approved products. Compounded medications have not been approved by the FDA and the FDA has not evaluated their safety or efficacy.
This content is for informational purposes only and does not constitute medical, financial, or insurance advice. Coverage rules, prior-authorization criteria, and copay amounts change frequently and vary by plan, formulary tier, and effective date — always verify current benefits directly with Security Health Plan before making any decision. Consult a licensed healthcare provider and your plan administrator for guidance specific to your situation. Curex offers compounded semaglutide and tirzepatide, which are not the same medications as Mounjaro and are not branded or FDA-approved products; prescription required, subject to provider review. Compounded medications have not been approved by the FDA and the FDA has not evaluated their safety or efficacy.